Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 47,670 | 126,269 | 37,689 | 22,601 | 23,260 |
| Cost of Goods | 1,426 | 742 | 589 | 1,138 | 933 |
| Gross Profit | 46,244 | 125,527 | 37,100 | 21,463 | 22,327 |
| Operating Expenses | 81,256 | 79,307 | 81,501 | 70,649 | 75,633 |
| Operating Income | -34,586 | 46,962 | -43,812 | -49,048 | -52,373 |
| Interest Expense | 6,684 | 7,940 | 8,010 | 5,001 | 5,095 |
| Other Income | 1 | -423 | 116 | 601 | 203 |
| Pre-tax Income | -41,269 | 38,599 | -51,706 | -53,448 | -57,265 |
| Income Tax | 130 | -121 | 106 | 134 | 149 |
| Net Income Continuous | -41,399 | 38,720 | -51,812 | -53,582 | -57,414 |
| Net Income | $-41,399 | $38,720 | $-51,812 | $-53,582 | $-57,414 |
| EPS Basic Total Ops | -7.95 | 7.80 | -10.34 | -10.64 | -11.54 |
| EPS Basic Continuous Ops | -8.00 | 7.80 | -10.29 | -10.68 | -11.55 |
| EPS Diluted Total Ops | -7.95 | 7.80 | -10.34 | -10.64 | -11.54 |
| EPS Diluted Continuous Ops | -8.00 | 7.80 | -10.29 | -10.68 | -11.55 |
| EBITDA(a) | $-34,166 | $47,438 | $-43,157 | $-48,140 | $-51,283 |